Autism clinical trials at UCSF
5 in progress, 2 open to eligible people
AB-2004 in Treatment of Adolescents With Irritability Associated With Autism Spectrum Disorder (ASD)
open to eligible people ages 13-17
The purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in adolescent participants, aged 13 to 17, with irritability associated with autism spectrum disorder.
San Francisco, California and other locations
Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
open to eligible people ages 6-17
This study will be conducted to evaluate the efficacy of GWP42003-P, compared with placebo, in reducing symptom severity in children with Autism Spectrum Disorder (ASD).
San Francisco, California and other locations
An Open Label Study of CM-AT for the Treatment of Children With Autism
Sorry, in progress, not accepting new patients
This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.
San Francisco, California and other locations
Building Resilience and Appropriate Independence in Young Adults With Autism
Sorry, in progress, not accepting new patients
This study evaluates the effects of a 12-week life-skills resilience curriculum for young adults with autism. The project utilizes a wait-list crossover design and compares the intervention to standard care.
San Francisco, California
Micronutrient Supplementation in Children With ASD
Sorry, not yet accepting patients
An open-label examination of changes in metabolites with use of micronutrients in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures monthly at school with teachers and parents report.
San Francisco, California
Our lead scientists for Autism research studies include Robert Hendren, DO.
Last updated: